Clinical Trials on Blood Lipidome
Total 94122 results
-
University of California, DavisCompletedGut Microbiome | Skin Microbiome | Gut Lipidome | Skin Lipidome | Blood LipidomeUnited States
-
University of California, DavisCompletedErythema | Microbiome | Skin Pigment | Side Effect | Wrinkle Appearance | LipidomeUnited States
-
Libbs Farmacêutica LTDACompletedArterial Hypertension | Blood Glucose, High | Cholesterol; LipidosisBrazil
-
University of AlicanteCompletedHypertension | Obesity | Body Weight | Diet, Healthy | Machine Learning | Cholesterol; LipidosisSpain
-
Fondazione SISA (Societa Italiana per lo Studio...Recruiting
-
Rabin Medical CenterGenzyme, a Sanofi CompanyUnknown
-
Monash University MalaysiaRecruiting
-
Istanbul UniversityBiruni UniversityNot yet recruitingLipid Storage DiseaseTurkey
-
University of TorontoUnknownCardiovascular Risk Factor | Cholesterol; LipidosisCanada
-
CENTOGENE GmbH RostockCompletedLysosomal Storage Diseases | Sphingolipidoses | Gaucher DiseaseAlbania, Greece, India, Israel, Morocco, Pakistan, Spain
-
Children's Mercy Hospital Kansas CityRecruiting
-
National Institute of Neurological Disorders and...CompletedGaucher's DiseaseUnited States
-
University of TorontoUnknownCardiovascular Diseases | Stroke | Inflammation | Diabetes | Blood Pressure | Coronary Heart Disease | Adiposity | Cardiovascular Risk Factor | Cholesterol; LipidosisCanada
-
Alexion PharmaceuticalsTerminatedLysosomal Acid Lipase DeficiencyUnited Kingdom, Finland, United States, Italy
-
PfizerNo longer availableGaucher DiseaseUnited States, Israel
-
Merck Sharp & Dohme LLCCompletedMixed Hyperlipidemia
-
Nordic Pharma, USANutrasource Pharmaceutical and Nutraceutical Services, Inc.Withdrawn
-
Beyond Batten Disease FoundationTheranexusActive, not recruitingBatten DiseaseUnited States
-
PfizerTerminatedMixed HyperlipidemiaUnited States, Canada, Czech Republic, Finland, France, Netherlands
-
Alexion PharmaceuticalsTerminatedLysosomal Acid Lipase DeficiencyUnited States
-
Sang Hak LeeUnknownMixed HyperlipidemiaKorea, Republic of
-
Amicus TherapeuticsActive, not recruiting
-
Alexion PharmaceuticalsCompletedLysosomal Acid Lipase DeficiencyFrance, Poland, United Kingdom, Spain, Mexico, Turkey, Japan, Australia, Russian Federation, United States, Germany, Italy, Czechia, Argentina, Croatia
-
Merck Sharp & Dohme LLCCompletedPrimary Hypercholesterolemia | Mixed Hyperlipidemia
-
Merck Sharp & Dohme LLCCompletedPrimary Hypercholesterolemia | Mixed Hyperlipidemia
-
Massachusetts General HospitalAlexion PharmaceuticalsUnknownCholesterol Ester Storage Disease | Lysosomal Acid Lipase DeficiencyUnited States
-
Chiesi Farmaceutici S.p.A.ICON plcNot yet recruiting
-
UniQure Biopharma B.V.Not yet recruiting
-
Brunel UniversityRoyal Free Hospital NHS Foundation TrustRecruiting
-
Institut National de la Santé Et de la Recherche...Not yet recruitingFabry Disease
-
SanofiCompletedFabry DiseaseUnited Arab Emirates
-
Amicus TherapeuticsActive, not recruitingFabry DiseaseUnited States, United Kingdom
-
Idorsia Pharmaceuticals Ltd.Active, not recruitingFabry DiseaseUnited States, United Kingdom, Norway, Germany, Australia, Canada, Spain, Switzerland, Austria, Belgium, France, Netherlands, Poland
-
Chiesi ItaliaCompleted
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseAustralia, Netherlands, United Kingdom, Canada, Czechia, Norway, Slovenia
-
Freeline TherapeuticsTerminatedLysosomal Storage Diseases | Fabry DiseaseUnited States, Norway, Germany, Austria, United Kingdom, Italy, Canada
-
Manchester University NHS Foundation TrustNorthern Care Alliance NHS Foundation TrustActive, not recruiting
-
Amicus TherapeuticsCompletedFabry DiseaseJapan, Taiwan, Turkey, United States, Brazil
-
ShireActive, not recruiting
-
ShireNo longer available
-
CENTOGENE GmbH RostockShire Human Genetic Therapies, Inc.CompletedCerebrovascular AccidentAustria, Belgium, Croatia, Finland, France, Georgia, Germany, Ireland, Italy, Malta, Poland, Portugal, Spain, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseFrance, Poland, United States, Russian Federation, United Kingdom
-
Lysosomal and Rare Disorders Research and Treatment...SanofiUnknown
-
Amicus TherapeuticsCompletedOpen-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry DiseaseFabry DiseaseUnited States, Austria, United Kingdom, Argentina, Australia, Belgium, Brazil, Canada, Denmark, Egypt, France, Italy, Japan, Spain, Turkey
-
Genzyme, a Sanofi CompanyTerminatedFabry DiseaseAustria, Brazil, France, United States, Argentina, Belgium, Canada, Finland, Hungary, Norway, Poland, Spain, Taiwan, United Kingdom
-
Boston Children's HospitalWithdrawn
-
University Hospital, BordeauxCompleted
-
Groupe Hospitalier Diaconesses Croix Saint-SimonTerminated
-
Amicus TherapeuticsCompletedFabry DiseaseFrance, Austria, United States, Belgium, Japan, United Kingdom, Denmark, Brazil, Australia, Italy